(Q48453608)

11 February 2018

title

Behavioral effects of modafinil in marmoset monkeys. (English)

1 reference

11 February 2018

1 reference

Sanneke A M van Vliet

1

1 reference

11 February 2018

Marjan J Jongsma

2

1 reference

11 February 2018

Raymond A P Vanwersch

3

1 reference

11 February 2018

Berend Olivier

4

1 reference

11 February 2018

Ingrid H C H M Philippens

5

1 reference

11 February 2018

publication date

21 March 2006

1 reference

11 February 2018

number of pages

8

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

11 February 2018

volume

185

1 reference

11 February 2018

issue

4

1 reference

11 February 2018

page(s)

433-440

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1007/s00213-006-0340-4

exact match

0 references

cites work

Zacopride: anxiolytic profile in rodent and primate models of anxiety

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-006-0340-4

Behavioral test systems in marmoset monkeys.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-006-0340-4

Modafinil binds to the dopamine uptake carrier site with low affinity.

21 January 2018

1 reference

12 December 2020

Dopaminergic role in stimulant-induced wakefulness.

1 reference

12 December 2020

Dopamine and noradrenaline receptor stimulation: reversal of reserpine-induced suppression of motor activity

1 reference

12 December 2020

An ethogram of the common marmoset (Calithrix jacchus jacchus): general behavioural repertoire

1 reference

12 December 2020

Preclinical pharmacology of ropinirole (SK&F 101468-A) a novel dopamine D2 agonist.

1 reference

12 December 2020

Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol

1 reference

12 December 2020

The role of GABA in the pathophysiology and treatment of anxiety disorders.

1 reference

12 December 2020

Clinical pharmacokinetic profile of modafinil

1 reference

12 December 2020

Prospective study of tardive dyskinesia in the elderly: rates and risk factors

1 reference

12 December 2020

Modafinil facilitates performance on a delayed nonmatching to position swim task in rats

1 reference

12 December 2020

Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease

1 reference

12 December 2020

The stimulant effect of modafinil on wakefulness is not associated with an increase in anxiety in mice. A comparison with dexamphetamine.

1 reference

12 December 2020

A simple automated test to measure exploratory and motor activity of marmosets.

1 reference

12 December 2020

Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil.

1 reference

12 December 2020

Hypothalamic arousal regions are activated during modafinil-induced wakefulness.

1 reference

12 December 2020

Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model

1 reference

12 December 2020

Successful treatment of excessive daytime sleepiness in Parkinson's disease with modafinil

1 reference

12 December 2020

Modafinil and cortical gamma-aminobutyric acid outflow. Modulation by 5-hydroxytryptamine neurotoxins

1 reference

12 December 2020

Treatment of excessive daytime sleepiness in patients with Parkinson's disease with modafinil

1 reference

12 December 2020

The effects of modafinil on striatal, pallidal and nigral GABA and glutamate release in the conscious rat: evidence for a preferential inhibition of striato-pallidal GABA transmission.

1 reference

12 December 2020

Cognitive enhancing effects of modafinil in healthy volunteers

1 reference

12 December 2020

Non-amphetaminic mechanism of stimulant locomotor effect of modafinil in mice

1 reference

12 December 2020

Excessive daytime sleepiness and sleep disturbances in patients with neurological diseases: epidemiology and management

1 reference

12 December 2020

Narcolepsy. Signs, symptoms, differential diagnosis, and management.

1 reference

12 December 2020

The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade.

1 reference

12 December 2020

The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: possible involvement of the serotonergic 5-HT3 receptor.

1 reference

12 December 2020

Modafinil augmentation of antidepressant treatment in depression.

1 reference

12 December 2020

The neurobiology of startle

1 reference

12 December 2020

Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults

1 reference

12 December 2020

Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat.

1 reference

12 December 2020

Modafinil improves recovery after general anesthesia

1 reference

12 December 2020

Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study

1 reference

12 December 2020

Central alpha 1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals

1 reference

12 December 2020

Modafinil treatment of opioid-induced sedation

1 reference

12 December 2020

Behavioural effects of anxiogenic agents in the common marmoset

1 reference

12 December 2020

Three Case Reports of Modafinil Use in Treating Sedation Induced by Antipsychotic Medications

1 reference

12 December 2020

Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: comparison with amphetamine.

1 reference

12 December 2020

Actions of caffeine in the brain with special reference to factors that contribute to its widespread use.

1 reference

12 December 2020

Adjunctive modafinil at initiation of treatment with a selective serotonin reuptake inhibitor enhances the degree and onset of therapeutic effects in patients with major depressive disorder and fatigue.

1 reference

12 December 2020

Antiparkinsonian and neuroprotective effects of modafinil in the mptp-treated common marmoset

1 reference

12 December 2020

Low dose quetiapine for drug induced dyskinesias in Parkinson's disease: a double blind cross over study

1 reference

12 December 2020

Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy

1 reference

12 December 2020

Non-human primate models for investigating fear and anxiety.

1 reference

12 December 2020

10.1007/S00213-006-0340-4

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

16550386

1 reference

11 February 2018